You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Claims for Patent: 9,179,899


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,179,899
Title:Implantable device
Abstract: In an implantable device (1) for use in the human and/or animal body for closure or partial closure of defect openings (2), cavities, organ passages etc or for providing a defined communicating opening between walls, organs, cavities etc comprising a carrier structure (17) which in a primary form has a large ratio of length to transverse extent along an axis (x) and in a secondary form has a smaller ratio of length to transverse extent along the axis (x), wherein the carrier structure (17) has a proximal and a distal portion (10, 11) and is formed in the manner of a weft and/or mesh and/or layered cloth and/or gauze, at least the one portion (11) in the secondary form has a first part (14) facing outwardly away from the other portion (10) or towards same and a second part (13) which deploys first from the primary form into the secondary form and which is folded back in a direction towards the other portion (10) or inwardly on to the first part (14).
Inventor(s): Freudenthal; Franz (La Paz, BO)
Assignee: PFM MEDICAL AG (Cologne, DE)
Application Number:11/973,267
Patent Claims:1. An implantable device for use in a human and/or animal body for closure or partial closure of defect openings, cavities or organ passages, or for providing a defined communicating opening between walls, organs or cavities comprising: a carrier structure which in a primary form has a large ratio of length to transverse extent along an axis and in a secondary form has a smaller ratio of length to transverse extent along the axis, wherein the carrier structure is in the form of a weft, mesh, layered cloth, gauze, or combination thereof, wherein: in the primary form said carrier structure comprises a distal portion comprising first and second segments, a proximal portion, and an intermediate portion between the distal and proximal portions, the second segment being at the distal end of the carrier structure adjacent the first segment, each portion and segment having an interior surface and an exterior surface, the distal and intermediate portions capable to deploy from the primary form into the secondary form; and in the secondary form, the first segment and the second segment define a substantially u-shaped structure as viewed in a longitudinal cross-section, in which the exterior surface of the first segment faces the exterior surface of the second segment, and the interior surface of the second segment faces the exterior surface of the intermediate portion in a direction towards the proximal portion, the first segment and intermediate portion forming a substantially n-shape structure, as viewed in a longitudinal cross-section, encompassing the second segment.

2. The implantable device as set forth in claim 1, wherein the intermediate portion has a diameter which is reduced in relation to the proximal and the distal portions.

3. The implantable device as set forth in claim 2, wherein the diameter of the intermediate portion, the diameter of a through opening extending through the implantable device, or a combination thereof is predeterminably dimensioned for providing a defined communicating opening between the walls, organs or cavities in the human and/or animal body.

4. The implantable device as set forth in claim 2, wherein the second part segment of the distal portion extends between said two legs such that it is close to the intermediate portion or bears against the intermediate portion.

5. The implantable device as set forth in claim 1, wherein at least the distal portion is of a substantially disk-shaped or bulging configuration in the secondary configuration.

6. The implantable device as set forth in claim 5, wherein the carrier structure has a substantially closed end.

7. The implantable device as set forth in claim 6, wherein the substantially closed end brings together ends of the carrier structure defined by said weft, mesh, layered cloth, gauze, or combination thereof.

8. The implantable device as set forth as set forth in claim 1, wherein the distal portion is substantially disk-shaped and the proximal portion is of a bulging configuration in the secondary configuration.

9. The implantable device as set forth in claim 1, wherein the implantable device is shaped to be adapted to a configuration at an implantation location as the secondary form.

10. The implantable device as set forth in claim 1, wherein the second part of the distal portion comprises a peripherally extending thin edge.

11. The implantable device as set forth in claim 1, wherein the carrier structure comprises a shape memory material or a plastic material.

12. The implantable device as set forth in claim 1, wherein the distal portion of the carrier structure is deployable independently of the proximal portion.

13. The implantable device as set forth in claim 1, wherein the carrier structure is formed from at least one wire-like element.

14. The implantable device as set forth in claim 13, wherein the at least one wire-like element is a round cross-sectional shape, a flat cross sectional shape, or a combination thereof.

15. The implantable device as set forth in claim 13, wherein the at least one wire like element comprises a plurality of wire like elements each having an end, wherein the ends of the wire like elements are woven together in a surface of the carrier structure.

16. The implantable device as set forth in claim 1, wherein the carrier structure forms one or more loops at an end of the carrier structure.

17. The implantable device as set forth in claim 16, wherein the one or more loops go into a twisted or interwoven portion.

18. The implantable device as set forth in claim 1, wherein at least one of the proximal and distal portions of the carrier structure is wound up in a helix-like configuration.

19. The implantable device as set forth in claim 18, wherein the distal portion is wound up in a helix-like configuration.

20. The implantable device as set forth in claim 18, wherein the at least one of the proximal and distal portions which is wound up in a helix-like configuration has a plurality of parts facing towards the other of the proximal and distal portions and a plurality of parts facing away from the other of the proximal and distal portions.

21. The implantable device as set forth in claim 18, wherein one of the proximal and distal portions of the carrier structure is wound up in a helix-like configuration and the other of the proximal and distal portions is of a different configuration from the portion which is wound up in a helix-like configuration.

22. The implantable device as set forth in claim 21, wherein the other of the proximal and distal portions is of a substantially flat configuration, a partially bulging configuration, a curved configuration, or a combination thereof.

23. The implantable device as set forth in claim 18, at least one of the proximal and distal portions comprises a through opening.

24. The implantable device as set forth in claim 18, at least one of the proximal and distal portions is substantially closed.

25. The implantable device as set forth in claim 1, wherein the carrier structure is of a hat-shaped configuration with at least one double-layer hat brim-shaped portion.

26. The implantable device as set forth in claim 25, wherein the double-layer hat brim-shaped portion is provided by the distal portion.

27. The implantable device as set forth in claim 25, wherein a head part-shaped portion of the carrier structure is arranged in opposite relationship to the hat brim-shaped portion, and is turned over inwardly into an interior of the implantable device.

28. The implantable device as set forth in claim 1 additionally including an ejection system for said implantable device and ejecting the implantation device in an implantation procedure, comprising at least one guide or ejection wire and at least one holding wire, wherein the at least one ejection wire is provided with a tip.

29. The implantable device having said ejection system as set forth in claim 28, wherein the tip is of a diameter of between about 0.1 and 0.3 mm.

30. The implantable device having said ejection system as set forth in claim 28, wherein the holding wire forms at least one loop for passing the ejection wire therethrough.

31. The implantable device having said ejection system as set forth in claim 30, wherein the holding wire is threadable through one or more end loops of the carrier structure for fixing to the implantable device.

32. The implantable device having said ejection system as set forth in claim 30, wherein the holding wire is threadable through a carrier ring interconnecting a plurality of end loops of the implantable device.

33. The implantable device having said ejection system as set forth in claim 28, wherein the implantable device is rotatable and floatable about the at least one ejection wire and the at least one holding wire.

34. An implantable device for use in the human and/or animal body for the closure or partial closure of defect openings, cavities or organ passages comprising: a carrier structure which can be reproducibly converted from a primary form into a secondary form which is imparted thereto, wherein the carrier structure has a proximal portion, a distal portion, and an intermediate portion connecting the proximal and distal portions, each portion and segment having an interior surface and an exterior surface, the carrier structure being in the form of a weft, a mesh, a layered cloth, a gauze, or a combination thereof and wherein: the distal portion comprises a first segment and a second segment; the first segment and the second segment define a substantially u-shaped structure as viewed in a longitudinal cross-section, in which the exterior surface of the first segment faces the exterior surface of the second segments, and the interior surface of the second segment faces the exterior surface of the intermediate portion in a direction towards the proximal portion, the first segment and intermediate portion forming a substantially n-shape structure, as viewed in a longitudinal cross-section, encompassing the second segment; and the distal portion is of an outwardly opening form and the proximal portion is of a bulging closed form.

35. The implantable device as set forth in claim 34, wherein at least one membrane element is provided in a region of the proximal portion, the distal portion the intermediate portion, or a combination thereof.

36. The implantable device as set forth in claim 35, wherein the membrane element is fixed to the carrier structure.

37. The implantable device as set forth in claim 35, wherein the membrane element is sewn to the carrier structure.

38. The implantable device as set forth in claim 35, wherein: the carrier structure comprises edge loops; and said implantable device further comprises a thread-like element looped around an edge of the membrane element and said edge loops, the thread-like element being knotted at one or more of said edge loops to fix the membrane element to the carrier structure.

39. The implantable device as set forth in claim 35, wherein dimensions of the membrane element approximately correspond to those of a defect opening to be closed.

40. The implantable device as set forth in claim 35, wherein the membrane element is configured and fixed to the implantable device such that the membrane element substantially completely covers over the distal portion when said implantable device is in the secondary form.

41. The implantable device as set forth in claim 35, wherein the membrane element comprises a plastic material.

42. The implantable device as set forth in claim 35, wherein at least one surface of the carrier structure, the membrane element, or a combination thereof is coated or treated with at least one functional material.

43. The implantable device as set forth in claim 42, wherein the functional material is selected from the group consisting of inorganic materials, ceramic materials, synthetic polymers, human biopolymers, medication coatings, medication-liberating polymers, biomolecules, functional groups and genetic materials.

44. The implantable device as set forth in claim 43, wherein the functional material is selected from the group consisting of gold, biogold, diamond-like carbon (DLC), diamond-like nanocomposite (DLN), iridium oxide, nanoporous Al203, silicon carbide, hydroxylapatite, titanium nitrite oxide, poly(2-chloro-p-xylylene), polybutylmethacrylate, phosphorylcholine, polyethylene, polyethylene vinylacetate, polyhexymethacrylate, poly[bis](trifluoroethoxy)phosphazene, polytetrafluoroethylene, polyurethane, collagen, chondroitin sulfate, elastin, fibrin, hydraluronic acid, abciximab, heparin, paclitaxel, abciximab-liberating cellulose, angiopeptin-liberating phosphorylcholine, DNA-liberating polyethylene vinylacetate or polybutylmethacrylate, a medication-liberating or substance-liberating poly(L-lactide), paclitaxel or hirudin or iloprost-liberating polylactide, viral vector-liberating polylactide-phosphorylcholine, forskolin-liberating polyurethane and stem cells.

45. The implantable device as set forth in claim 42, wherein the at least one surface of the carrier structure is treated by plasma treatment, a PVD process, a CVD process, ion implantation, sputtering, an ion beam process, a laser process, a thermal process, spin coating, dip coating, etching or electropolishing.

46. The implantable device as set forth in claim 34, wherein the carrier structure acts as a membrane element.

47. The implantable device as set forth in claim 34, wherein the implantable device is of a concentric or eccentric form.

48. The implantable device as set forth in claim 34, wherein the carrier structure automatically adapts to a configuration at an implantation location.

49. The implantable device as set forth in claim 48, wherein the carrier structure is adapted to or is designed to be adaptable to the implantation location in any direction.

50. The implantable device as set forth in claim 34, wherein the carrier structure comprises twisted wire-like elements which are woven together or interlaced or mutually twisted portions of wire-like elements which are woven through each other at intersection points individually or in the form of twisted elements.

51. The implantable device as set forth in claim 34, wherein the carrier structure is formed from at least one wire-like element in a single-layer, double-layer or multi-layer configuration.

52. The implantable device as set forth in claim 51, wherein the carrier structure is formed of one or more individual layers or strata comprised of the same material.

53. The implantable device as set forth in claim 52, wherein at least one of the layers comprises shape memory material, at least one of the layers comprises polyester and at least one of the layers comprises PTFE.

54. The implantable device as set forth in claim 52, wherein at least one membrane element is arranged between at least two layers of the carrier structure.

55. The implantable device as set forth in claim 51, wherein the carrier structure is formed of one or more individual layers or strata comprised of different materials.

56. The implantable device as set forth in claim 34, further comprising a marker for visually indicating the implantable device under a monitoring apparatus during an implantation procedure.

57. The implantable device as set forth in claim 56, wherein the marker is a micro spiral provided at an edge on the implantable device.

58. The implantable device as set forth in claim 56, wherein the marker comprises an X-ray-visible material containing between 70 and 90% platinum and between 30 and 10% iridium.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.